Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
BioTech
Consumer Health
Pharmaceuticals
Medical Devices
About Investor
Leen Kawas is the Managing General Partner at Propel Bio Partners, focusing on investments from $100K to $5.0M in medical devices, biotech, pharmaceuticals, consumer health, and health IT sectors at seed to Series B stages. She is based in Los Angeles, California. Her recent investment includes the biotech company Geneoscopy. Leen has a strong background in life sciences and healthcare venture capital, emphasizing transformative health technologies.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP